These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36353608)

  • 1. Cigarette smoking induces the activation of RIP2/caspase-12/NF-
    Qian Y; Wang W; Chen D; Zhu Y; Wang Y; Wang X
    PeerJ; 2022; 10():e14330. PubMed ID: 36353608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette Smoke Modulates NOD1 Signal Pathway and Human β Defensins Expression in Human Oral Mucosa.
    Qian YJ; Wang X; Gao YF; Duan N; Huang XF; Sun FF; Han XD; Wang WM
    Cell Physiol Biochem; 2015; 36(2):457-73. PubMed ID: 25968832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-12 silencing attenuates inhibitory effects of cigarette smoke extract on NOD1 signaling and hBDs expression in human oral mucosal epithelial cells.
    Wang X; Qian YJ; Zhou Q; Ye P; Duan N; Huang XF; Zhu YN; Li JJ; Hu LP; Zhang WY; Han XD; Wang WM
    PLoS One; 2014; 9(12):e115053. PubMed ID: 25503380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene silencing of receptor-interacting protein 2 protects against cigarette smoke-induced acute lung injury.
    Dong J; Liao W; Tan LH; Yong A; Peh WY; Wong WSF
    Pharmacol Res; 2019 Jan; 139():560-568. PubMed ID: 30394320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
    Chang XS; Zhu J; Yang T; Gao Y
    Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD1, RIP2 and Caspase12 are potentially novel biomarkers for oral squamous cell carcinoma development and progression.
    Wang X; Jiang W; Duan N; Qian Y; Zhou Q; Ye P; Jiang H; Bai Y; Zhang W; Wang W
    Int J Clin Exp Pathol; 2014; 7(4):1677-86. PubMed ID: 24817964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF-κB signaling by increasing IκBα degradation.
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Cell Biol Int; 2022 May; 46(5):806-818. PubMed ID: 35128752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway.
    Sun X; Chai L; Wang B; Zhou J
    Arch Oral Biol; 2024 Nov; 167():106068. PubMed ID: 39151326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions.
    Sarkar A; Duncan M; Hart J; Hertlein E; Guttridge DC; Wewers MD
    J Immunol; 2006 Apr; 176(8):4979-86. PubMed ID: 16585594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoke extract induces oral squamous cell carcinoma cell invasion in a receptor for advanced glycation end-products-dependent manner.
    Chapman S; Mick M; Hall P; Mejia C; Sue S; Abdul Wase B; Nguyen MA; Whisenant EC; Wilcox SH; Winden D; Reynolds PR; Arroyo JA
    Eur J Oral Sci; 2018 Feb; 126(1):33-40. PubMed ID: 29226456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA DCST1-AS1 Facilitates Oral Squamous Cell Carcinoma by Promoting M2 Macrophage Polarization through Activating NF-
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Zou C
    J Immunol Res; 2021; 2021():5524231. PubMed ID: 34414241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
    Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
    Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
    Hu D; Zhong T; Dai Q
    Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of VAP-1 in OSCC suppresses tumor growth and metastasis via NF-κB/IL-8 signaling and reduces neutrophil infiltration.
    Xu Q; Chen X; Yu T; Tang Q; Zhou Z; Wang H; Huang W; Huang T; Liang F
    J Oral Pathol Med; 2022 Apr; 51(4):332-341. PubMed ID: 35174543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53/NF-κB pathway.
    Yao Y; Zhou WY; He RX
    Biomed Pharmacother; 2019 Jan; 109():1994-2004. PubMed ID: 30551455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling.
    Ma J; Na S; Wang P; Li J; He S; Liu F
    Cancer Biother Radiopharm; 2024 Mar; 39(2):144-152. PubMed ID: 35549438
    [No Abstract]   [Full Text] [Related]  

  • 19. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation.
    Ruefli-Brasse AA; Lee WP; Hurst S; Dixit VM
    J Biol Chem; 2004 Jan; 279(2):1570-4. PubMed ID: 14638696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.